Paper Details

  1. Home
  2. Paper Details

Anticholinergic medication for non-clozapine neuroleptic-induced hypersalivation in people with schizophrenia.

Author: AlhafezBishr, Alhaj HasanNahla, AltujjarMohammad, EssaliAdib, RihawiAnas, TarboushAmjad

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

While medications called neuroleptics are commonly used to treat schizophrenia, they can cause excessive saliva production, which can be embarrassing and difficult to manage. This side effect can impact quality of life and even lead to people stopping their medication.
Paper Details　
Original Abstract of the Article :
Treatment of schizophrenia depends heavily on neuroleptic drugs. Hypersalivation is a common side effect when people with schizophrenia are treated with neuroleptic drugs. Hypersalivation can be an embarrassing and stigmatising problem, can affect quality of life and can result in discontinuation of...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD009546.pub2

データ提供：米国国立医学図書館（NLM）

Anticholinergic Medication for Neuroleptic-Induced Hypersalivation

Hypersalivation, a common side effect of neuroleptic drugs used to treat schizophrenia, can significantly impact quality of life. This review explores the use of anticholinergic medication to manage non-clozapine neuroleptic-induced hypersalivation in individuals with schizophrenia. The review discusses the challenges associated with hypersalivation, its impact on quality of life, and the potential benefits of anticholinergic medication in alleviating this distressing symptom.

Managing a Challenging Side Effect: A Review of Anticholinergics

This review delves into the challenges associated with hypersalivation, a common side effect of neuroleptic drugs used to treat schizophrenia. Similar to a camel seeking relief from the harsh desert sun, this review explores the potential of anticholinergic medication to alleviate this distressing symptom. The review highlights the importance of understanding the underlying mechanisms and the potential benefits of anticholinergic treatment for managing this challenging side effect.

Finding Solutions for Hypersalivation: A Look at Treatment Options

This review underscores the importance of finding effective solutions for hypersalivation, a side effect that can significantly impact the quality of life of individuals with schizophrenia. It provides valuable information about the potential role of anticholinergic medication in managing this challenging symptom. The review encourages further research to optimize treatment strategies and improve the well-being of those affected by hypersalivation.

Dr. Camel's Conclusion

This review provides valuable insights into the use of anticholinergic medication to manage hypersalivation, a common side effect of neuroleptic drugs used to treat schizophrenia. The review highlights the challenges associated with this side effect and the potential benefits of anticholinergic treatment. It underscores the importance of ongoing research to develop effective and well-tolerated strategies for managing hypersalivation and improving the quality of life for individuals with schizophrenia.

Date :
  1. Date Completed 2014-04-02
  2. Date Revised 2022-04-09
Further Info :

Pubmed ID

24353163

DOI: Digital Object Identifier

10.1002/14651858.CD009546.pub2

Related Literature

Article Analysis
・Effective treatment of schizophrenia
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.